Results 241 to 250 of about 117,497 (280)
BRD9 at the crossroads of splicing, chromatin remodeling, and hematopoiesis. [PDF]
Yamasaki T, Nishimura K, Inoue D.
europepmc +1 more source
A case of T-prolymphocytic leukemia harboring RAS mutation. [PDF]
Perrone S +9 more
europepmc +1 more source
Spontaneous remission of congenital acute megakaryoblastic leukemia in a neonate with down syndrome. [PDF]
Yang W, Sui S, Hao S.
europepmc +1 more source
Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function. [PDF]
Arnold DE +23 more
europepmc +1 more source
Secondary Chronic Myeloid Leukemia in the Blast Phase With Mixed Phenotype After Radiation Therapy: A Case Report. [PDF]
Aoki M +6 more
europepmc +1 more source
Metabolic and epigenetic interplay in HSPC specification: A balance between extrinsic and intrinsic cues. [PDF]
Kalogeraki M +4 more
europepmc +1 more source
MLL (myeloid/lymphoid or mixed lineage leukemia)
Jl Huret
exaly +7 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Food & Function, 2022
Relapse of leukemia and drug resistance are still the major obstacles to therapy due to leukemia-initiating stem/progenitor cells (LICs); thus, targeting them using safe compounds is crucial. Here, we evaluated the anti-leukemic effect of royal jelly (RJ)
Marwa M. Abu‐Serie, Noha H. Habashy
semanticscholar +1 more source
Relapse of leukemia and drug resistance are still the major obstacles to therapy due to leukemia-initiating stem/progenitor cells (LICs); thus, targeting them using safe compounds is crucial. Here, we evaluated the anti-leukemic effect of royal jelly (RJ)
Marwa M. Abu‐Serie, Noha H. Habashy
semanticscholar +1 more source

